140 related articles for article (PubMed ID: 36514298)
1. JCAD: a new GWAS target to reduce residual cardiovascular risk?
Guzik TJ; Channon KM
Eur Heart J; 2023 May; 44(20):1834-1836. PubMed ID: 36514298
[TBL] [Abstract][Full Text] [Related]
2. JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
Liberale L; Puspitasari YM; Ministrini S; Akhmedov A; Kraler S; Bonetti NR; Beer G; Vukolic A; Bongiovanni D; Han J; Kirmes K; Bernlochner I; Pelisek J; Beer JH; Jin ZG; Pedicino D; Liuzzo G; Stellos K; Montecucco F; Crea F; Lüscher TF; Camici GG
Eur Heart J; 2023 May; 44(20):1818-1833. PubMed ID: 36469488
[TBL] [Abstract][Full Text] [Related]
3. A key role for the novel coronary artery disease gene JCAD in atherosclerosis via shear stress mechanotransduction.
Douglas G; Mehta V; Al Haj Zen A; Akoumianakis I; Goel A; Rashbrook VS; Trelfa L; Donovan L; Drydale E; Chuaiphichai S; Antoniades C; Watkins H; Kyriakou T; Tzima E; Channon KM
Cardiovasc Res; 2020 Sep; 116(11):1863-1874. PubMed ID: 31584065
[TBL] [Abstract][Full Text] [Related]
4. Association of a genetic variant in the AKT gene locus and cardiovascular risk factors.
Kermanshahi F; Ghazizadeh H; Hussein NA; Amerizadeh F; Samadi S; Tayefi M; Kamel Khodabandeh A; Moohebati M; Ebrahimi M; Esmaily H; Sahebi R; Abdulkarimi R; Mousavi SAR; Ferns GA; Avan A; Ghayour-Mobarhan M
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):57-64. PubMed ID: 32538748
[TBL] [Abstract][Full Text] [Related]
5. The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis.
Xu S; Xu Y; Liu P; Zhang S; Liu H; Slavin S; Kumar S; Koroleva M; Luo J; Wu X; Rahman A; Pelisek J; Jo H; Si S; Miller CL; Jin ZG
Eur Heart J; 2019 Aug; 40(29):2398-2408. PubMed ID: 31539914
[TBL] [Abstract][Full Text] [Related]
6. Whole-Genome Approach Discovers Novel Genetic and Nongenetic Variance Components Modulated by Lifestyle for Cardiovascular Health.
Zhou X; van der Werf J; Carson-Chahhoud K; Ni G; McGrath J; Hyppönen E; Lee SH
J Am Heart Assoc; 2020 Apr; 9(8):e015661. PubMed ID: 32308100
[TBL] [Abstract][Full Text] [Related]
7. Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention.
Juul Rasmussen I; Rasmussen KL; Nordestgaard BG; Tybjærg-Hansen A; Frikke-Schmidt R
Eur Heart J; 2020 Nov; 41(41):4024-4033. PubMed ID: 33022702
[TBL] [Abstract][Full Text] [Related]
8. Translating GWAS data into cardiovascular disease prevention - the Finnish experience.
Niiranen TJ
Blood Press Monit; 2022 Dec; 27(Suppl 1):e9-e10. PubMed ID: 36445439
[No Abstract] [Full Text] [Related]
9. Cardiovascular diseases and genome-wide association studies.
Ndiaye NC; Azimi Nehzad M; El Shamieh S; Stathopoulou MG; Visvikis-Siest S
Clin Chim Acta; 2011 Sep; 412(19-20):1697-701. PubMed ID: 21672533
[TBL] [Abstract][Full Text] [Related]
10. Understanding cardiovascular disease through the lens of genome-wide association studies.
Arking DE; Chakravarti A
Trends Genet; 2009 Sep; 25(9):387-94. PubMed ID: 19716196
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies of cardiovascular disease.
Walsh R; Jurgens SJ; Erdmann J; Bezzina CR
Physiol Rev; 2023 Jul; 103(3):2039-2055. PubMed ID: 36634218
[TBL] [Abstract][Full Text] [Related]
12. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease.
Kessler T; Vilne B; Schunkert H
EMBO Mol Med; 2016 Jul; 8(7):688-701. PubMed ID: 27189168
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.
Yao C; Chen G; Song C; Keefe J; Mendelson M; Huan T; Sun BB; Laser A; Maranville JC; Wu H; Ho JE; Courchesne P; Lyass A; Larson MG; Gieger C; Graumann J; Johnson AD; Danesh J; Runz H; Hwang SJ; Liu C; Butterworth AS; Suhre K; Levy D
Nat Commun; 2018 Aug; 9(1):3268. PubMed ID: 30111768
[TBL] [Abstract][Full Text] [Related]
14. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
Kones R
Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
[TBL] [Abstract][Full Text] [Related]
15. Statistical and Functional Studies Identify Epistasis of Cardiovascular Risk Genomic Variants From Genome-Wide Association Studies.
Li Y; Cho H; Wang F; Canela-Xandri O; Luo C; Rawlik K; Archacki S; Xu C; Tenesa A; Chen Q; Wang QK
J Am Heart Assoc; 2020 Apr; 9(7):e014146. PubMed ID: 32237974
[TBL] [Abstract][Full Text] [Related]
16. Gene discovery for high-density lipoprotein cholesterol level change over time in prospective family studies.
Feitosa MF; Lunetta KL; Wang L; Wojczynski MK; Kammerer CM; Perls T; Schupf N; Christensen K; Murabito JM; Province MA
Atherosclerosis; 2020 Mar; 297():102-110. PubMed ID: 32109663
[TBL] [Abstract][Full Text] [Related]
17. Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia.
Juul Rasmussen I; Frikke-Schmidt R
Eur Heart J; 2023 Jul; 44(28):2526-2543. PubMed ID: 37224508
[TBL] [Abstract][Full Text] [Related]
18. From genome-wide association studies to functional genomics: new insights into cardiovascular disease.
McPherson R
Can J Cardiol; 2013 Jan; 29(1):23-9. PubMed ID: 23200092
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular risk factors from an aging perspective].
Peters MJL; Beulens JWJ; Muller M
Ned Tijdschr Geneeskd; 2023 Jan; 167():. PubMed ID: 36633020
[TBL] [Abstract][Full Text] [Related]
20. Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes.
Zhang X; Johnson AD; Hendricks AE; Hwang SJ; Tanriverdi K; Ganesh SK; Smith NL; Peyser PA; Freedman JE; O'Donnell CJ
Hum Mol Genet; 2014 Feb; 23(3):782-95. PubMed ID: 24057673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
